Major Depressive Disorder Clinical Trial
Official title:
A Phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Major Depressive Disorder
This is a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of PRAX-114 in participants with moderate to severe major depressive disorder (MDD). Participants will be randomized to receive 28 days of either 40 mg PRAX-114 or placebo in a 1:1 ratio.
n/a
| NCT number | NCT04832425 |
| Study type | Interventional |
| Source | Praxis Precision Medicines |
| Contact | Chief Medical Officer, Praxis Precision Medicines |
| Phone | 617-300-8460 |
| [email protected] | |
| Status | Recruiting |
| Phase | Phase 2/Phase 3 |
| Start date | March 30, 2021 |
| Completion date | April 2022 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
| Recruiting |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
| Suspended |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
Early Phase 1 | |
| Not yet recruiting |
NCT04556890 -
Pain and Major Depressive Disorder
|
N/A | |
| Recruiting |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
| Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
| Active, not recruiting |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
| Active, not recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
| Recruiting |
NCT04422652 -
Combination of Novel Therapies for CKD Comorbid Depression
|
Phase 3 | |
| Recruiting |
NCT04799405 -
Home-based tDCS in Major Depressive Disorder
|
N/A | |
| Recruiting |
NCT03708159 -
Maintenance of Response After rTMS for Depression Using tDCS
|
N/A | |
| Recruiting |
NCT03363919 -
Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression
|
N/A | |
| Recruiting |
NCT04634669 -
Open-Label Safety Study of AXS-05 in Subjects With TRD
|
Phase 2 | |
| Recruiting |
NCT03307070 -
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
|
N/A | |
| Completed |
NCT03113890 -
McLean and Genomind Prospective Study
|
N/A | |
| Recruiting |
NCT02674529 -
Study of Neural Responses Induced by Antidepressant Effects
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT02934035 -
Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
|
N/A | |
| Completed |
NCT02309060 -
Storytelling Video Intervention for Depressed Primary Care Patients - Open Trial
|
N/A | |
| Not yet recruiting |
NCT02766920 -
Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone
|
N/A | |
| Completed |
NCT02939560 -
TMS for Adults With Autism and Depression
|
N/A |